Skye Bioscience, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit and Redeemable Convertible Series B and Convertible Series C & D Preferred Stock (Detail Textuals 1)

Stockholders' Deficit and Redeemable Convertible Series B and Convertible Series C & D Preferred Stock (Detail Textuals 1) - USD ($)	1 Months Ended		3 Months Ended			9 Months Ended
	Oct. 20, 2015	Oct. 31, 2014	Sep. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Equity [Line Items]
Recognized stock-based compensation expense			$ 181,608			$ 544,823
Total amount of unrecognized compensation cost related to non-vested stock options			1,048,158			$ 1,048,158
Recognized period of non-vested stock options						2 years 1 month 24 days
General and administrative expense
Equity [Line Items]
Recognized stock-based compensation expense			$ 152,172	$ 187,550	$ 181,608	$ 456,510	$ 544,823
Omnibus Incentive Plan 2014 \| Stock Option
Equity [Line Items]
Number of shares reserved for future grants		3,200,000
Aggregate number of shares granted						0
Number of shares available for future grant		870,000
Expiry period of options granted		10 years
Percentage of option price at least of fair value on date of grants		100.00%
Voting percentage of common stock		10.00%
Percentage of fair value option price at date of grants		110.00%
Maximum exercisable period of fair value of option		5 years
Vested period of shares		5 years
Weighted average remaining contractual term of options vested and exercisable (in years)						7 years 1 month 21 days
Options to purchase shares of common stock, exercisable			452,000			452,000
Options outstanding		1,130,000	1,130,000			1,130,000		1,142,500
Aggregate intrinsic value of options outstanding			$ 0			$ 0
Omnibus Incentive Plan 2014 \| Restricted stock awards
Equity [Line Items]
Recognized stock-based compensation expense			65,625			196,875
Total amount of unrecognized compensation cost related to non-vested stock options			$ 284,375			$ 284,375
Omnibus Incentive Plan 2014 \| Restricted stock awards \| Senior management and board of directors
Equity [Line Items]
Number of restricted stock awards granted	$ 1,200,000
Fair market value of shares granted	$ 900,000
Omnibus Incentive Plan 2014 \| Restricted stock awards \| Minimum \| Senior management and board of directors
Equity [Line Items]
Vested period of shares	1 year
Omnibus Incentive Plan 2014 \| Restricted stock awards \| Maximum \| Senior management and board of directors
Equity [Line Items]
Vested period of shares	3 years